Literature DB >> 11312027

Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.

K Yang1, S Wang, K O Chang, S Lu, L J Saif, H B Greenberg, J P Brinker, J E Herrmann.   

Abstract

Intramuscular (i.m.) injection of murine VP6 DNA vaccines raised high titers of rotavirus-specific serum IgG and IgA antibodies in BALB/c mice. A Th1-like antibody response was generated based on the ratio of serum IgG2a to IgG1 antibodies. Rotavirus-specific serum IgA but not fecal IgA was detected in mice prior to rotavirus challenge. Partial protection against rotavirus challenge was achieved as measured by reduction of rotavirus antigen shedding in feces. A similar level of protection was found with a bovine rotavirus VP6 DNA vaccine against a murine rotavirus challenge, suggesting that heterologous protection can be obtained by immunizing with VP6 DNA vaccines. We did not directly test for cytotoxic T lymphocyte (CTL) activity, but in vivo depletion of CD8+ T cells in mice immunized with a murine VP6 DNA vaccine did not significantly change the duration of virus shedding or the pattern of protection obtained. This finding suggested that CD8+ CTL activity was not essential for the partial protection we obtained by i.m. immunization of mice with VP6 DNA vaccines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312027     DOI: 10.1016/s0264-410x(00)00543-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Induction of mucosal immunity through systemic immunization: Phantom or reality?

Authors:  Fei Su; Girishchandra B Patel; Songhua Hu; Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

3.  HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.

Authors:  Andrea S Laimbacher; Laura E Esteban; Alejandro A Castello; Juan C Abdusetir Cerfoglio; Marcelo H Argüelles; Graciela Glikmann; Alejandra D'Antuono; Nora Mattion; Mabel Berois; Juan Arbiza; Monika Hilbe; Elisabeth M Schraner; Michael Seyffert; Christiane Dresch; Alberto L Epstein; Mathias Ackermann; Cornel Fraefel
Journal:  Mol Ther       Date:  2012-06-19       Impact factor: 11.454

4.  Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits.

Authors:  Eric Soler; Agnès Le Saux; Frédéric Guinut; Bruno Passet; Ruxandra Cohen; Christine Merle; Annie Charpilienne; Cynthia Fourgeux; Véronique Sorel; Antoine Piriou; Isabelle Schwartz-Cornil; Jean Cohen; Louis-Marie Houdebine
Journal:  Transgenic Res       Date:  2005-12       Impact factor: 2.788

Review 5.  Current status of rotavirus vaccines.

Authors:  Ching-Min Wang; Shou-Chien Chen; Kow-Tong Chen
Journal:  World J Pediatr       Date:  2015-10-11       Impact factor: 2.764

6.  Development of a Bacillus subtilis-based rotavirus vaccine.

Authors:  Sangun Lee; Boris R Belitsky; James P Brinker; Kathryn O Kerstein; David W Brown; John D Clements; Gerald T Keusch; Saul Tzipori; Abraham L Sonenshein; John E Herrmann
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

Review 7.  Rotavirus vaccines.

Authors:  G Kang
Journal:  Indian J Med Microbiol       Date:  2006-10       Impact factor: 0.985

8.  Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.

Authors:  Suvi Lappalainen; Ana Ruth Pastor; Maria Malm; Vanessa López-Guerrero; Fernando Esquivel-Guadarrama; Laura A Palomares; Timo Vesikari; Vesna Blazevic
Journal:  Arch Virol       Date:  2015-05-29       Impact factor: 2.574

9.  Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys.

Authors:  Zi Han Kang; Christine A Bricault; Erica N Borducchi; Kathryn E Stephenson; Michael S Seaman; Maria Pau; Hanneke Schuitemaker; Danielle van Manen; Frank Wegmann; Dan H Barouch
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 10.  Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge?

Authors:  Ada Maria Barcelos Alves; Simone Morais Costa; Paolla Beatriz Almeida Pinto
Journal:  Front Med Technol       Date:  2021-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.